SG11201408473UA - Methods for inactivation of viruses and bacteria in cell culture media - Google Patents
Methods for inactivation of viruses and bacteria in cell culture mediaInfo
- Publication number
- SG11201408473UA SG11201408473UA SG11201408473UA SG11201408473UA SG11201408473UA SG 11201408473U A SG11201408473U A SG 11201408473UA SG 11201408473U A SG11201408473U A SG 11201408473UA SG 11201408473U A SG11201408473U A SG 11201408473UA SG 11201408473U A SG11201408473U A SG 11201408473UA
- Authority
- SG
- Singapore
- Prior art keywords
- media
- san francisco
- lllll
- south san
- international
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32061—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36061—Methods of inactivation or attenuation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261662349P | 2012-06-20 | 2012-06-20 | |
US13/844,051 US9493744B2 (en) | 2012-06-20 | 2013-03-15 | Methods for viral inactivation and other adventitious agents |
PCT/US2013/046756 WO2013192395A1 (en) | 2012-06-20 | 2013-06-20 | Methods for inactivation of viruses and bacteria in cell culture media |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201408473UA true SG11201408473UA (en) | 2015-01-29 |
Family
ID=48746128
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201408473UA SG11201408473UA (en) | 2012-06-20 | 2013-06-20 | Methods for inactivation of viruses and bacteria in cell culture media |
SG10201707017XA SG10201707017XA (en) | 2012-06-20 | 2013-06-20 | Methods for inactivation of viruses and bacteria in cell culture media |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201707017XA SG10201707017XA (en) | 2012-06-20 | 2013-06-20 | Methods for inactivation of viruses and bacteria in cell culture media |
Country Status (22)
Country | Link |
---|---|
US (4) | US9493744B2 (pt) |
EP (2) | EP3205715A1 (pt) |
JP (3) | JP6607779B2 (pt) |
KR (2) | KR20200034829A (pt) |
CN (2) | CN104603261A (pt) |
AR (1) | AR091508A1 (pt) |
AU (2) | AU2013277118B2 (pt) |
BR (1) | BR112014031853B1 (pt) |
CA (1) | CA2875997C (pt) |
DK (1) | DK2864471T3 (pt) |
ES (1) | ES2625060T3 (pt) |
HK (1) | HK1210215A1 (pt) |
HU (1) | HUE032812T2 (pt) |
IL (1) | IL236144B (pt) |
MX (2) | MX365381B (pt) |
MY (1) | MY192975A (pt) |
PL (1) | PL2864471T3 (pt) |
RU (1) | RU2685203C2 (pt) |
SG (2) | SG11201408473UA (pt) |
SI (1) | SI2864471T1 (pt) |
WO (1) | WO2013192395A1 (pt) |
ZA (1) | ZA201409172B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9493744B2 (en) * | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
BE1024230B1 (fr) * | 2016-11-08 | 2017-12-20 | Univercells Sa | Production contenue de cellules et/ou de produits cellulaires |
JP2021533760A (ja) | 2018-08-10 | 2021-12-09 | ジェネンテック, インコーポレイテッド | タンパク質グリコシル化を調節するための細胞培養戦略 |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4153509A (en) * | 1977-10-17 | 1979-05-08 | Union Carbide Corporation | Microbial production of hydroxylated biphenyl compounds |
USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
GB2048981B (en) | 1979-05-23 | 1982-11-17 | Coal Ind | Equipment for laying a layer of elongate material adjacent to an exposed rock or mineral surface in an underground mine |
USRE30385E (en) | 1979-07-16 | 1980-08-26 | American Cyanamid Company | Light and heat stabilizers for polyolefins |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4992363A (en) | 1983-11-09 | 1991-02-12 | Thomas Jefferson University | Method for preparing glucose free media for storing blood platelets |
JPH0825902B2 (ja) * | 1985-02-21 | 1996-03-13 | 株式会社ミドリ十字 | γ−グロブリンの加熱処理方法 |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US5091178A (en) | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
US4762714A (en) | 1986-04-08 | 1988-08-09 | Miles Laboratories, Inc. | Preparation of retrovirus-free immunoglobulins |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
DE3816139A1 (de) | 1987-10-17 | 1989-04-27 | Bayer Ag | Verfahren zur herstellung von paramunitaetsinducern |
ATE94351T1 (de) | 1987-12-28 | 1993-10-15 | Procter & Gamble | Herstellung von fruchtsaftgetraenken durch dispersion einer calziumhydroxidaufschlaemmung in einen strom von pasteurisiertem saft. |
US4872919A (en) | 1988-01-28 | 1989-10-10 | The Procter & Gamble Company | Method for removing precipitated calcium citrate from juice pasteurization or sterilization equipment |
EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
CA2068204C (en) | 1989-11-22 | 2002-02-12 | Arthur Levinson | Latency associated peptides and uses therefor |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
GB2251249B (en) | 1990-12-28 | 1995-06-21 | Mogam Biotech Res Inst | High-density medium for animal cell culture |
ES2241710T3 (es) | 1991-11-25 | 2005-11-01 | Enzon, Inc. | Procedimiento para producir proteinas multivalentes de union a antigeno. |
US5378488A (en) | 1993-06-10 | 1995-01-03 | Abbott Laboratories | Aseptic processing of infant formula |
AU695766B2 (en) * | 1993-12-01 | 1998-08-20 | Novo Nordisk Biotech, Inc. | (Aspergillus) expression system |
US5856179A (en) | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
US5484720A (en) | 1994-09-08 | 1996-01-16 | Genentech, Inc. | Methods for calcium phosphate transfection |
ATE228170T1 (de) * | 1994-09-08 | 2002-12-15 | Genentech Inc | Verfahren zur kalziumphosphat-transfektion |
US6043092A (en) | 1996-03-18 | 2000-03-28 | University Of Pittsburgh | Cell culture media for mammalian cells |
JP2000512128A (ja) * | 1997-03-12 | 2000-09-19 | ユニバーシティ・オブ・ピッツバーグ | 哺乳類細胞用の細胞培養培地 |
AT405608B (de) * | 1997-04-08 | 1999-10-25 | Immuno Ag | Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material |
PT1200606E (pt) | 1999-08-12 | 2006-12-29 | Pfizer Prod Inc | Gene de streptomyces avermitilis que regula a proporção de avermectinas b2:b1 |
WO2002056824A2 (en) * | 2000-08-10 | 2002-07-25 | Boston Biomedica, Inc. | Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines |
WO2003062458A2 (en) * | 2002-01-24 | 2003-07-31 | Ecopia Biosciences Inc. | Method, system and knowledge repository for identifying a secondary metabolite from a microorganism |
GB0304799D0 (en) | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
KR101185656B1 (ko) * | 2003-06-18 | 2012-09-24 | 디에스엠 아이피 어셋츠 비.브이. | 포자를 형성할 수 없는 미생물을 사용한 판토텐산염의 제조방법 |
JP4825409B2 (ja) | 2004-08-31 | 2011-11-30 | 株式会社日本触媒 | 光学用面状熱可塑性樹脂成形体、これを用いる偏光板および液晶表示装置 |
JP2008532554A (ja) | 2005-03-17 | 2008-08-21 | ハーキュリーズ・インコーポレーテッド | 食品および飲料の加熱加工中のファウリングを減少させる方法 |
CN103952376A (zh) * | 2008-09-24 | 2014-07-30 | 米迪缪尼有限公司 | 培养细胞、增殖和纯化病毒的方法 |
PT2464725T (pt) | 2009-08-11 | 2020-05-21 | Hoffmann La Roche | Produção de proteínas em meios de cultura celular isentos de glutamina |
JP5293499B2 (ja) * | 2009-08-24 | 2013-09-18 | 旭硝子株式会社 | リン酸カルシウムの沈着を抑制したコラーゲンビトリゲル |
US20150337269A1 (en) | 2012-04-10 | 2015-11-26 | Genentech, Inc. | Methods for inactivation of viruses and bacteria in cell culture media |
US9493744B2 (en) | 2012-06-20 | 2016-11-15 | Genentech, Inc. | Methods for viral inactivation and other adventitious agents |
-
2013
- 2013-03-15 US US13/844,051 patent/US9493744B2/en active Active
- 2013-06-19 AR ARP130102176 patent/AR091508A1/es active IP Right Grant
- 2013-06-20 CA CA2875997A patent/CA2875997C/en active Active
- 2013-06-20 MX MX2014015751A patent/MX365381B/es active IP Right Grant
- 2013-06-20 JP JP2015518574A patent/JP6607779B2/ja active Active
- 2013-06-20 AU AU2013277118A patent/AU2013277118B2/en active Active
- 2013-06-20 CN CN201380031879.XA patent/CN104603261A/zh active Pending
- 2013-06-20 CN CN202211385409.0A patent/CN115491340A/zh active Pending
- 2013-06-20 BR BR112014031853-0A patent/BR112014031853B1/pt active IP Right Grant
- 2013-06-20 RU RU2015101506A patent/RU2685203C2/ru active
- 2013-06-20 HU HUE13733496A patent/HUE032812T2/en unknown
- 2013-06-20 SG SG11201408473UA patent/SG11201408473UA/en unknown
- 2013-06-20 EP EP17155514.7A patent/EP3205715A1/en active Pending
- 2013-06-20 MY MYPI2014003493A patent/MY192975A/en unknown
- 2013-06-20 EP EP13733496.7A patent/EP2864471B1/en not_active Revoked
- 2013-06-20 PL PL13733496T patent/PL2864471T3/pl unknown
- 2013-06-20 DK DK13733496.7T patent/DK2864471T3/en active
- 2013-06-20 ES ES13733496.7T patent/ES2625060T3/es active Active
- 2013-06-20 WO PCT/US2013/046756 patent/WO2013192395A1/en active Application Filing
- 2013-06-20 SG SG10201707017XA patent/SG10201707017XA/en unknown
- 2013-06-20 KR KR1020207008350A patent/KR20200034829A/ko not_active Application Discontinuation
- 2013-06-20 SI SI201330626A patent/SI2864471T1/sl unknown
- 2013-06-20 KR KR1020157001027A patent/KR102095073B1/ko active IP Right Grant
-
2014
- 2014-12-09 IL IL236144A patent/IL236144B/en active IP Right Grant
- 2014-12-12 ZA ZA2014/09172A patent/ZA201409172B/en unknown
- 2014-12-17 MX MX2019006336A patent/MX2019006336A/es unknown
-
2015
- 2015-11-04 HK HK15110885.0A patent/HK1210215A1/xx unknown
-
2016
- 2016-10-11 US US15/290,986 patent/US10184106B2/en active Active
-
2017
- 2017-09-14 JP JP2017176710A patent/JP2018019711A/ja active Pending
-
2019
- 2019-04-05 AU AU2019202400A patent/AU2019202400A1/en not_active Abandoned
- 2019-07-18 US US16/515,929 patent/US20200216799A1/en not_active Abandoned
- 2019-12-04 JP JP2019219265A patent/JP2020062019A/ja active Pending
-
2022
- 2022-09-27 US US17/954,128 patent/US20230159886A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201903454VA (en) | Immunologically discernible cell surface variants for use in cell therapy | |
SG11201406903SA (en) | Cell culture compositions and methods for polypeptide production | |
SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
SG11201806663TA (en) | Closed-ended linear duplex dna for non-viral gene transfer | |
SG11201909432SA (en) | Compounds for increasing genome editing efficiency | |
SG11201407486PA (en) | Compositions and methods for modulating utrn expression | |
SG11201808528VA (en) | Modified wound dressings | |
SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
SG11201809912UA (en) | Hybrid carriers for nucleic acid cargo | |
SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
SG11201804372PA (en) | Tracking and manipulating cellular rna via nuclear delivery of crispr/cas9 | |
SG11201804373VA (en) | Compositions and methods for immunooncology | |
SG11201807025SA (en) | Crispr/cas systems for c-1 fixing bacteria | |
SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
SG11201804510PA (en) | Biparatopic polypeptides antagonizing wnt signaling in tumor cells | |
SG11201407669QA (en) | Methods for improving safety of blood-brain barrier transport | |
SG11201408405WA (en) | Engineered three-dimensional connective tissue constructs and methods of making the same | |
SG11201900038QA (en) | Compositions and methods comprising improvements of crispr guide rnas using the h1 promoter | |
SG11201908326YA (en) | Methods of treating neurodegenerative diseases | |
SG11201407483YA (en) | Compositions and methods for modulating smn gene family expression | |
SG11201407793TA (en) | Compounds and compositions for modulating egfr activity | |
SG11201407802WA (en) | Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy | |
SG11201407370QA (en) | Humanized il-7 rodents | |
SG11201408761VA (en) | Purification of iduronate-2-sulfatase | |
SG11201408037SA (en) | Humanized anti-trka antibodies with amino acid substitutions |